James Heyward

发表

Ambulatory noninsulin treatment of type 2 diabetes mellitus in the United States, 2015 to 2019

R. Kalyani, G. Alexander, James Heyward, 2021, Diabetes, obesity & metabolism.

Lower Use of Biologics for the Treatment of Asthma in Publicly-insured Individuals.

G. Alexander, James Heyward, C. Keet, 2021, The journal of allergy and clinical immunology. In practice.

Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy.

Lorenzo Bertizzolo, Tianjing Li, Kay Dickersin, 2017, Journal of clinical epidemiology.

Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018

T. J. Moore, P. Lurie, G. Alexander, 2020, Annals of Internal Medicine.

Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis

Sonal Singh, G. Alexander, James Heyward, 2020, PloS one.

Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events.

E. Mayo-Wilson, S. Vedula, K. Dickersin, 2019, Journal of clinical epidemiology.

Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration: A Review.

E. Stuart, P. Lurie, G. Alexander, 2019, JAMA internal medicine.

Danio rerio in K-12 classrooms: sparking interest in the new generation of scientists.

T. Esch, Ryan McElroy, James Heyward, 2009, Zebrafish.

Trends in Insulin Types and Devices Used by Adults With Type 2 Diabetes in the United States, 2016 to 2020

R. Kalyani, G. Alexander, James Heyward, 2021, JAMA network open.

Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review

Susan Hutfless, Elizabeth A. Stuart, Tianjing Li, 2015, Systematic Reviews.

Correction to: Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review

E. Stuart, E. Mayo-Wilson, S. Vedula, 2018, Alzheimer's Research & Therapy.

The Value of U.S. Pharmacopeial Standards: A Review of the Literature.

G. Alexander, W. Padula, James Heyward, 2018, Journal of pharmaceutical sciences.

Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products

P. Lurie, G. Alexander, J. Sharfstein, 2019, JAMA.

Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US

Dima M. Qato, G. Caleb Alexander, R. Stafford, 2020, JAMA network open.

Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

G. Anderson, G. Alexander, James Heyward, 2020, BMJ Open.

Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers

Christopher M. Jones, W. Compton, G. Alexander, 2018, JAMA network open.

National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020

R. Eckel, M. Blaha, R. Blumenthal, 2022, Journal of the American Heart Association.

Assessing Heterogeneity of Treatment Effect in Real-World Data

R. Varadhan, James Heyward, F. Nyberg, 2023, Annals of Internal Medicine.

CARDIOLOGIST USE OF SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS SINCE RELEASE OF FAVORABLE CARDIOVASCULAR OUTCOMES TRIALS: A NATIONAL STUDY

M. Blaha, G. Alexander, James Heyward, 2021 .

Assessing Heterogeneity of Treatment Effect in Real-World Data

Nicholas C. Henderson, R. Varadhan, James Heyward, 2023, Annals of Internal Medicine.

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers

Christopher M. Jones, W. Compton, G. Alexander, 2018, JAMA network open.

Setting Priorities for Diabetic Retinopathy Clinical Research and Identifying Evidence Gaps.

Ava K. Bittner, K. Dickersin, Tianjing Li, 2017, Ophthalmology. Retina.

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events.

E. Mayo-Wilson, S. Vedula, K. Dickersin, 2019, Journal of clinical epidemiology.

Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.

Christopher M. Jones, G. Alexander, Andrew J. Kolodny, 2021, Drug and alcohol dependence.

Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development

T. Nolin, L. Inker, G. Alexander, 2023, Clinical journal of the American Society of Nephrology : CJASN.

Clinical trial registration and reporting: a survey of academic organizations in the United States

E. Mayo-Wilson, D. Ford, G. Alexander, 2018, BMC Medicine.

Association between sodium-glucose cotransporter 2 (SGLT2) Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review inhibitors and lower extremity amputation: A systematic review and meta-analysis and meta-analysis

James Heyward, O. Mansour, Lily Olson, 2021 .

Telemedicine and Office-Based Care for Behavioral and Psychiatric Conditions During the COVID-19 Pandemic in the United States

G. Alexander, R. Mojtabai, James Heyward, 2020, Annals of Internal Medicine.